This information was published on 2025-05-31T00:06:47 for IP Right Acceptance Published.
| Field | Value |
| (210) | 2519645 (IR 1837689) |
| (220) |
30 Dec 2024
|
| (511) (510) |
Class 5
Pharmaceutical preparations for the treatment of skeletal or chondrocyte disorders; pharmaceutical preparations for the treatment of myeloproliferative disorders; pharmaceutical preparations for the treatment of graft versus host disorder (GVHD); pharmaceutical preparations for the treatment of dermatological disorders; pharmaceutical preparations for the treatment of fibrotic disorders; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of hematological disorders; pharmaceutical preparations for the treatment of immunological disorders; pharmaceutical preparations for the treatment of hypophosphatemia disorders. Class 16 Printed brochures, newsletters, and pamphlets in the fields of medical issues, procedures, disease symptoms, patient support and community building. Class 44 Providing medical information to healthcare providers and patients relating to viral, hematological, auto-immune, graft versus host, inflammatory, metabolic, fibrotic, skeletal, chondrocyte and dermatological disorders. |
| (540) | QPARIKO |
| (550) | Word |
| (730) |
Incyte Holdings Corporation
|
Find out more about publications on the About page.